LAVIPHARM S.A. NA EO 1 Cash Flow Reinvestment Rate
LAVIPHARM S.A. NA EO 1 cash flow reinvestment rate. LAVIPHARM S.A. NA EO 1 (BXA0) has a Cash Flow Reinvestment Rate of 2.08x as of December 2024, reinvesting €9.64 Million (capex €9.64 Million ) from operating cash flow of €4.64 Million. See financial agility of LAVIPHARM S.A. NA EO 1 to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of LAVIPHARM S.A. NA EO 1 (2021–2024)
Cash flow reinvestment rate of LAVIPHARM S.A. NA EO 1 from 2021 to 2024. Historical reinvestment intensity for LAVIPHARM S.A. NA EO 1 across 4 annual periods. Explore BXA0 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
LAVIPHARM S.A. NA EO 1 Cash Flow Reinvestment Rate by Year (2021–2024)
LAVIPHARM S.A. NA EO 1 cash flow reinvestment rate by year from 2021 to 2024. Year-by-year capital reinvestment analysis for LAVIPHARM S.A. NA EO 1. For the full cash flow conversion analysis, see BXA0 cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.08x | €9.64 Million | €4.64 Million | €9.64 Million | ▼ -85.4% |
| 2023 | 14.26x | €4.05 Million | €284.00K | €4.05 Million | ▲ +33.9% |
| 2022 | 10.64x | €35.62 Million | €3.35 Million | €35.62 Million | ▲ +2181.6% |
| 2021 | 0.47x | €1.92 Million | €4.11 Million | €1.92 Million | — |